UBS Group’s Burcon NutraScience Corporation BRCN Stock Holding History

UBS Group’s Portfolio BRCN Stock Details BRCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,566	Closed	-$2K	–	11684
2022 Q2	$2K	Buy	4,566 +2,499	+121%	+$1.62K	﹤0.01%	9761
2022 Q1	$2K	Sell	2,067 -5,596	-73%	-$5.47K	﹤0.01%	9803
2021 Q4	$9K	Sell	7,663 -101,323	-93%	-$135K	﹤0.01%	8988
2021 Q3	$170K	Sell	108,986 -146,763	-57%	-$342K	﹤0.01%	5440
2021 Q2	$714K	Buy	+255,749	New	+$818K	﹤0.01%	4466

Other funds holding BRCN

FFG

Frisch Financial Group Melville, New York $478M AUM 16.28% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

UBS Group's BRCN Position: Q3 2022 in Review

UBS Group sold out of Burcon NutraScience Corporation (BRCN) in Q3 2022, closing a stake of 4,566 shares — an estimated $2K sold.

UBS Group first reported a position in BRCN in Q2 2021 and held it in 5 quarters. The position peaked at $714K in Q2 2021. 2 funds tracked by Wall St. Rank hold BRCN as of Q3 2022.

UBS Group reported no remaining Burcon NutraScience Corporation position as of Q3 2022 after selling out during the quarter.
UBS Group sold 4,566 Burcon NutraScience Corporation shares in Q3 2022, an estimated $2K.
UBS Group first reported a position in Burcon NutraScience Corporation in Q2 2021 and held it in 5 quarters.
UBS Group's Burcon NutraScience Corporation position peaked at $714K in Q2 2021.
2 funds tracked by Wall St. Rank held Burcon NutraScience Corporation as of Q3 2022.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.